CN

Christopher F. Nicodemus

QP Quest Pharmatech: 3 patents #5 of 15Top 35%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
University of California: 1 patents #8,022 of 18,278Top 45%
Overall (All Time): #556,597 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11351255 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Ragupathy Madiyalakan 2022-06-07
10975163 Methods of increasing delivery of anti-cancer agents to targets Ragupathy Madiyalakan, Michael Anthony Hollingsworth 2021-04-13
10537636 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant Ragupathy Madiyalakan 2020-01-21
10392444 Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer Ragupathy Madiyalakan 2019-08-27
8945566 Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease Birgit Schultes 2015-02-03
8697079 IgE antibodies for the treatment of cancer Manuel L. Penichet, Birgit Schultes, Tracy R. Daniels, Gustavo Helguera, JOSE A. RODRIGUEZ 2014-04-15
8038994 Combination therapy for treating disease Birgit Schultes, Antoine Noujaim, Ragupathy Madiyalakan 2011-10-18
5317085 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response Richard L. Stevens, John H. Weis 1994-05-31
5171674 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response Richard L. Stevens, John H. Weis 1992-12-15